EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors

Milena Urbini iD, Sara Bleve, Giuseppe Schepisi iD, Cecilia Menna, Giorgia Gurioli iD, Caterina Gianni iD, Ugo De Giorgi iD

International Journal of Molecular Sciences · 28.11.2023 · 24 (23) · 16872

DOI: 10.3390/ijms242316872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.11.2023. Verfasst von Milena Urbini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The outcome of metastatic testicular germ cell tumor patients has been dramatically improved by cisplatin-based chemotherapy combinations. However, up to 30% of patients with advanced disease relapse after first-line therapy and require salvage regimens, which include treatments with conventional-dose chemotherapy or high-dose chemotherapy with autologous stem cell transplantation. For these patients, prognosis estimation represents an essential step in the choice of medical treatment but still remains a complex challenge. The available histological, clinical, and biochemical parameters attempt to define the prognosis, but they do not reflect the tumor’s molecular and pathological features and do not predict who will exhibit resistance to the several treatments. Molecular selection of patients and validated biomarkers are highly needed in order to improve current risk stratification and identify novel therapeutic approaches for patients with recurrent disease. Biomolecular biomarkers, including microRNAs, gene expression profiles, and immune-related biomarkers are currently under investigation in testicular germ cell tumors and could potentially hold a prominent place in the future treatment selection and prognostication of these tumors. The aim of this review is to summarize current scientific data regarding prognostic and predictive biomarkers for salvage therapy in testicular germ cell tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalMaleHumansSalvage TherapyAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Recurrence, LocalTransplantation, AutologousCisplatinBiomarkers

Stichwörter der Autor:innen

biomarkersgerm cell tumorsimmunotherapymicroRNAmolecular alterationssalvage therapytesticular cancers

Substanzen

CisplatinBiomarkers

Autor:innen und Institutionen

  • Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.

ORCID-Profile: Milena Urbini, Giuseppe Schepisi, Giorgia Gurioli, Caterina Gianni, Ugo De Giorgi

Förderung

  • Italian Ministry of Health

Zitieren

APA

Urbini, M., Bleve, S., Schepisi, G., Menna, C., Gurioli, G., Gianni, C., & De Giorgi, U. (2023). Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors. International Journal of Molecular Sciences, 24(23), 16872. https://doi.org/10.3390/ijms242316872

Vancouver

Urbini M, Bleve S, Schepisi G, Menna C, Gurioli G, Gianni C, et al. Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors. International Journal of Molecular Sciences. 2023;24(23):16872. doi:10.3390/ijms242316872

BibTeX
@article{Urbini2023,
  author = {Urbini, Milena and Bleve, Sara and Schepisi, Giuseppe and Menna, Cecilia and Gurioli, Giorgia and Gianni, Caterina and De Giorgi, Ugo},
  title = {Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {23},
  pages = {16872},
  doi = {10.3390/ijms242316872}
}
Kostenlos starten →